Insulet Corp reports results for the quarter ended March 31 - Earnings Summary
08/05/2025 22:01
Insulet Corp PODD.OQ reported quarterly adjusted earnings of $1.01 per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 73 cents. The mean expectation of twenty two analysts for the quarter was for earnings of 80 cents per share. Wall Street expected results to range from 70 cents to $1.16 per share. Revenue rose 28.8% to $569.00 million from a year ago; analysts expected $543.40 million. Insulet Corp's reported EPS for the quarter was 50 cents. The company reported quarterly net income of $35.4 million. Insulet Corp shares had risen by 0.6% this quarter and gained 1.2% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 3.5% in the last three months. In the last 30 days, there have been no negative revisions of earnings estimates RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 20 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" Wall Street's median 12-month price target for Insulet Corp is $323.00 This summary was machine generated from LSEG data May 8 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Mar. 31 2025 | 0.80 | 1.01 | Beat |
| Dec. 31 2024 | 1.02 | 1.15 | Beat |
| Sep. 30 2024 | 0.76 | 0.90 | Beat |
| Jun. 30 2024 | 0.56 | 0.55 | Missed |